Corporates
2012
11-50 Employees
YumabThe biotech company YUMAB develops and generates fully human antibodies against targets for customers and partners worldwide. Therefore, it uses its own universal and one of the world's largest fully human antibody library. Evolutionary technologies lead directly to optimized antibodies for further development into drugs. Currently, YUMAB gains importance in Lower Saxony through the development of a drug against SARS-CoV-2 together with its subsidiary CORAT Therapeutics.
Address
Inhoffenstraße 7, 38124 Brunswick, Germany
Commercial Register
GmbH
HRB 203964
Banners
Lower Saxony Innovation PrizeThe state of Lower Saxony is seeking outstanding projects that actively shape and strengthen the region's position as a center of innovation – apply now for the Lower Saxony Innovation Award. The award recognizes companies that have (further) developed a technology that has the potential to drive and shape the long-term transformation of Lower Saxony's economic and innovation system. This award recognizes innovations that can, or are already, paving the way for further technological innovations in Lower Saxony. Consortia that have successfully combined their efforts to translate business insights into practical applications in an exemplary manner will also be recognized. This year, the Lower Saxony Innovation Award is once again under the patronage of Olaf Lies, Lower Saxony's Minister for Economic Affairs, Transport, Construction and Digitalization, and Falko Mohrs, Lower Saxony's Minister for Science and Culture.